Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulation by HLA class I-derived peptides

A M Krensky1, C Clayberger

  • 1Department of Pediatrics, Stanford University School of Medicine, California 94305-5119, USA.

Transplantation Proceedings
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.

Oncogene·2016
Same author

Biology and clinical relevance of granulysin.

Tissue antigens·2009
Same author

Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins.

International journal of immunopathology and pharmacology·2008
Same author

Forest bathing enhances human natural killer activity and expression of anti-cancer proteins.

International journal of immunopathology and pharmacology·2007
Same author

Chemokines and allograft rejection: narrowing the list of suspects.

Transplantation·2001
Same author

Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes.

The Journal of infectious diseases·2001
Same journal

Analysis of the Cost of Maintaining Effective Donors and Nondonors of Organs and Tissues in Intensive Care Units.

Transplantation proceedings·2026
Same journal

Adolescence and Pediatric Heart Transplantation: Impact of Non-Adherence on Mortality: A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Impact of Family-Based Care on the Outcome of Brain Death and Humanization in the Process of Multiple Organ Donation: Case Report.

Transplantation proceedings·2026
Same journal

Karnofsky Performance Status Is Associated with Patient and Graft Survival After Liver Retransplantation.

Transplantation proceedings·2026
Same journal

Evaluating CMV Risk Stratification, Donor Characteristics, and Post-Transplant Outcomes in Kidney Transplant Recipients: A Retrospective Eurotransplant Center Analysis.

Transplantation proceedings·2026
Same journal

Twenty-One Years of Insights From A Single-Center Living Kidney Donation Program.

Transplantation proceedings·2026
See all related articles

Synthetic peptides mimicking HLA class I molecules show therapeutic promise for immune disorders and transplantation. These peptides modulate immune responses, including inhibiting Natural Killer (NK) cell activity, highlighting new immunotherapy targets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Therapeutic Development

Background:

  • Synthetic peptides based on Human Leukocyte Antigen (HLA) class I sequences exhibit significant immunomodulatory properties.
  • These peptides have demonstrated efficacy in both laboratory (in vitro) and living organism (in vivo) settings.
  • Clinical studies are exploring their potential for treating conditions like transplant rejection and immune-mediated diseases.

Purpose of the Study:

  • To investigate the immunomodulatory effects of synthetic HLA class I peptides.
  • To evaluate their therapeutic potential in transplantation and immune-mediated diseases.
  • To identify new immunotherapy targets based on peptide interactions with immune cells.

Main Methods:

  • Synthesis of peptides corresponding to linear sequences of HLA class I molecules.

Related Experiment Videos

  • In vitro and in vivo studies to assess immunomodulatory effects.
  • Analysis of peptide interactions with T cells and Natural Killer (NK) cells.

    • Main Results:

    • Synthetic HLA class I peptides induce profound immunomodulatory effects.
    • These peptides inhibit NK cell responses in human subjects.
    • The carboxy end of the alpha 1 alpha helix is crucial for negative signaling to T cells and NK cells.

    Conclusions:

    • Synthetic peptides targeting HLA class I molecules represent a promising therapeutic strategy.
    • Their ability to inhibit NK cell activity opens avenues for novel immunotherapies.
    • Understanding the role of the alpha 1 alpha helix in signaling can guide the development of targeted immunomodulatory agents.